TerminatedNot Applicable

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)

Stopped: Halted Prematurely

Portugal25 participantsStarted 2020-01-27

Plain-language summary

Anticoagulants are used to prevent thrombotic events in patients with predisposing factors. However, the use of such therapies is associated with bleeding complications, which can be a serious safety issue. Thus, it is important to evaluate the safety and effectiveness of such therapies based on data collected in clinical practice in order to generate relevant scientific data that could be used to support clinical and regulatory decisions. This is an open, prospective, multicenter, observational cohort study that aims to prospectively record the clinical history of adult patients receiving anticoagulant treatment, irrespectively of the prescribed drug and the indication for its use.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged ≥18 years; * Patients who, at the time of inclusion, have been receiving for no more than 30 days or are about to start anticoagulation therapy - irrespectively of the prescribed drug, the dosage, and the indication for its use; * Availability to sign an informed consent form. Exclusion Criteria: * Not available for follow-up and constant monitoring; * Participation in phase II or III clinical studies\*; * Life-expectancy \<6 months, non-residents in the Participant region, or planning to leave in the next 6 months.

What they're measuring

Incidence of complications

Timeframe: At least 12 months of follow-up

Trial details

NCT IDNCT03977363

SponsorCHAD

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-03-02

View on ClinicalTrials.gov More Atrial Fibrillation trials